Literature DB >> 11055760

Causes and costs of hospitalization of tuberculosis patients in the United States.

Z Taylor1, S M Marks, N M Ríos Burrows, S E Weis, R L Stricof, B Miller.   

Abstract

OBJECTIVE: To examine the costs, lengths of stay and patient characteristics associated with tuberculosis (TB) hospitalizations.
METHODS: A prospective cohort study of 1493 TB patients followed from diagnosis to completion of therapy at 10 public health programs and area hospitals in the US. The main outcome measures were the following: 1) occurrence, 2) cost, and 3) length of stay of TB-related hospitalizations.
RESULTS: There were 821 TB-related hospitalizations among the study participants; 678 (83%) were initial hospitalizations and 143 (17%) were hospitalizations during the treatment of TB. Patients infected with human immunodeficiency virus (HIV) (OR 1.8, 95% CI 1.2-2.6), and homeless patients (OR, 1.7 95% CI 1.1-2.8) were at increased risk of being hospitalized at diagnosis. Homeless patients (RR 2.5, 95%CI 1.5-4.3), patients who used alcohol excessively (RR 1.9, 95% CI 1.2-3.0), and patients with multidrug-resistant TB (RR 5.7, 95% CI 2.7-11.8) were at increased risk of hospitalization during treatment. The median length of stay varied from 9 to 17 days, and median costs per hospitalization varied from $6441 to $12968 among the sites.
CONCLUSION: Important social factors, HIV infection, and local hospitalization practice patterns contribute significantly to the high cost of TB-related hospitalizations. Efforts to address these specific factors are needed to reduce the cost of preventable hospitalizations.

Entities:  

Mesh:

Year:  2000        PMID: 11055760      PMCID: PMC5448276     

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  19 in total

1.  Health care delivery in Maine I: patterns of use of common surgical procedures.

Authors:  J E Wennberg; A Gittelsohn
Journal:  J Maine Med Assoc       Date:  1975-05

2.  Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1997-05-02

3.  Population illness rates do not explain population hospitalization rates. A comment on Mark Blumberg's thesis that morbidity adjusters are needed to interpret small area variations.

Authors:  J E Wennberg
Journal:  Med Care       Date:  1987-04       Impact factor: 2.983

4.  Small area variations in health care delivery.

Authors:  J Wennberg
Journal:  Science       Date:  1973-12-14       Impact factor: 47.728

5.  Small area variations in health care delivery in Maryland.

Authors:  A Gittelsohn; N R Powe
Journal:  Health Serv Res       Date:  1995-06       Impact factor: 3.402

6.  The economic impact of tuberculosis in hospitals in New York City: a preliminary analysis.

Authors:  P S Arno; C J Murray; K A Bonuck; P Alcabes
Journal:  J Law Med Ethics       Date:  1993 Fall-Winter       Impact factor: 1.718

7.  Tuberculosis then and now: a personal perspective on the last 50 years.

Authors:  G L Snider
Journal:  Ann Intern Med       Date:  1997-02-01       Impact factor: 25.391

8.  Access to community-based medical services and number of hospitalizations among patients with HIV disease: are they related?

Authors:  W E Cunningham; D M Mosen; R D Hays; R M Andersen; M F Shapiro
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996-12-01

9.  Tuberculosis control policies in major metropolitan health departments in the United States. IV. Standards in 1988.

Authors:  D R Leff; A R Leff
Journal:  Am Rev Respir Dis       Date:  1989-06

10.  Medical care costs of intravenous drug users with AIDS in Brooklyn.

Authors:  C L Bennett; A Pascal; M Cvitanic; V Graham; A Kitchens; J A DeHovitz
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992
View more
  42 in total

Review 1.  Medical management of drug-sensitive active thoracic tuberculosis: the work-up, radiographic findings and treatment.

Authors:  Jared Eddy; Taimur Khan; Frank Schembri
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

2.  The cost structure of lung tuberculosis in Germany.

Authors:  Roland Diel; Bernhard Rappenhöner; Tom Schaberg
Journal:  Eur J Health Econ       Date:  2004-10

3.  Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States.

Authors:  D Shepardson; S M Marks; H Chesson; A Kerrigan; D P Holland; N Scott; X Tian; A S Borisov; N Shang; C M Heilig; T R Sterling; M E Villarino; W R Mac Kenzie
Journal:  Int J Tuberc Lung Dis       Date:  2013-12       Impact factor: 2.373

4.  Factors influencing development and mortality of acute respiratory failure in hospitalized patient with active pulmonary tuberculosis: a 10-year retrospective review.

Authors:  Rungsun Bhurayanontachai; Kunlatida Maneenil
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

5.  Priorities for screening and treatment of latent tuberculosis infection in the United States.

Authors:  Benjamin P Linas; Angela Y Wong; Kenneth A Freedberg; C Robert Horsburgh
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

6.  Homelessness and Mortality Among Persons With Tuberculosis in Texas, 2010-2017.

Authors:  Saroochi Agarwal; Duc T Nguyen; Edward A Graviss
Journal:  Public Health Rep       Date:  2019-09-20       Impact factor: 2.792

7.  Tuberculosis hospitalization expenditures per patient from private health insurance claims data, 2010-2014.

Authors:  K Owusu-Edusei; S M Marks; R Miramontes; E L Stockbridge; C A Winston
Journal:  Int J Tuberc Lung Dis       Date:  2017-04-01       Impact factor: 2.373

8.  Number and cost of hospitalizations with principal and secondary diagnoses of tuberculosis, United States.

Authors:  M V Aslam; K Owusu-Edusei; S M Marks; G R B Asay; R Miramontes; M Kolasa; C A Winston; P M Dietz
Journal:  Int J Tuberc Lung Dis       Date:  2018-12-01       Impact factor: 2.373

9.  Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection.

Authors:  David P Holland; Gillian D Sanders; Carol D Hamilton; Jason E Stout
Journal:  Am J Respir Crit Care Med       Date:  2009-03-19       Impact factor: 21.405

10.  Eliminating tuberculosis one neighborhood at a time.

Authors:  J Peter Cegielski; David E Griffith; Paul K McGaha; Melanie Wolfgang; Celia B Robinson; Patricia A Clark; Willis L Hassell; Valerie A Robison; Kerfoot P Walker; Charles Wallace
Journal:  Am J Public Health       Date:  2012-10-18       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.